title: Phenotypic study of a case receiving a keratolimbal allograft and amniotic membrane for total limbal stem cell deficiency.
abstract: OBJECTIVE
  To report the expression pattern of key molecules by the reconstructed corneal epithelium after a keratolimbal allograft (KLAL) and amniotic membrane transplantation (AMT) for total limbal stem cell deficiency.
  
  
  METHODS
  Interventional case report.
  
  
  METHODS
  A 50-year-old woman with severe chemical burns in both eyes received an AMT as a temporary patch at the acute stage, and a KLAL with AMT as a graft at the chronic stage for total limbal stem cell deficiency. The corneal button removed during subsequent corneal transplantation was submitted for immunofluorescence staining with monoclonal antibodies against keratin K3, MUC5AC, connexin 43, integrins alpha3beta1 and alpha6beta4, and laminin 5 for comparison with a normal cornea.
  
  
  RESULTS
  Histologically, a normal stratified corneal epithelium has five to six cell layers that lay on the thick amniotic membrane basement membrane. The phenotype was of a corneal origin, based on expression of positive keratin K3, negative MUC5AC, and positive connexin 43. Furthermore, intact basement membrane complexes were present, evidenced by positive staining to integrins alpha3beta1 and alpha6beta4 and to laminin 5.
  
  
  CONCLUSIONS
  A normal corneal epithelial phenotype with normal basement membrane complexes was restored after a KLAL and AMT in a case with total limbal stem cell deficiency.
authors.affiliation: Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami School of Medicine, Miami, FL 33176, USA.
authors.forename: Edgar M
authors.initials: EM
authors.lastname: Espana
authors.forename: Martin
authors.initials: M
authors.lastname: Grueterich
authors.forename: Seng Ei
authors.initials: SE
authors.lastname: Ti
authors.forename: Scheffer C G
authors.initials: SC
authors.lastname: Tseng
mesh_terms: D000650:Amnion / Q000637:transplantation*; D015415:Biomarkers / Q000032:analysis; D002057:Burns, Chemical / Q000378:metabolism / Q000601:surgery*; D018031:Connexin 43 / Q000378:metabolism; D003316:Corneal Diseases / Q000378:metabolism / Q000601:surgery*; D004847:Epithelial Cells / Q000166:cytology / Q000378:metabolism; D019573:Epithelium, Corneal / Q000378:metabolism / Q000637:transplantation*; D005126:Eye Burns / Q000139:chemically induced* / Q000378:metabolism; D005260:Female; D019084:Fluorescent Antibody Technique, Indirect; D006801:Humans; D016130:Immunophenotyping; D039201:Integrin alpha3beta1 / Q000378:metabolism; D039161:Integrin alpha6beta4 / Q000378:metabolism; D007633:Keratins / Q000378:metabolism; D015948:Keratoplasty, Penetrating; D007797:Laminin / Q000378:metabolism; D016850:Limbus Corneae / Q000166:cytology* / Q000378:metabolism; D008875:Middle Aged; D055271:Mucin 5AC; D009077:Mucins / Q000378:metabolism; D033581:Stem Cell Transplantation; D013234:Stem Cells / Q000166:cytology / Q000378:metabolism; D014021:Tissue Preservation; D014792:Visual Acuity
chemical_list: D015415:Biomarkers; D018031:Connexin 43; D039201:Integrin alpha3beta1; D039161:Integrin alpha6beta4; D007797:Laminin; C524678:MUC5AC protein, human; D055271:Mucin 5AC; D009077:Mucins; C095567:laminin alpha 3; D007633:Keratins